Humana Inc. vs General Mills, Inc. Price Comparison: Which Stock Offers Greater Value?

Humana Inc., with a stock price of $350.08, trades at a high valuation compared to General Mills, which is priced at only $33.15. The PE ratio further emphasizes this disparity, with Humana at 37.32 versus General Mills’ much lower 8.11, signaling that the healthcare stock is valued more richly relative to its earnings. This higher valuation can be justified by Humana’s larger market capitalization of approximately $42.03 billion, making it a dominant player in the healthcare plans industry, while General Mills’ market cap stands at roughly $17.69 billion, reflecting its status as a leading packaged foods company.

From a price-focused investment perspective, General Mills offers a compelling entry point due to its lower stock price and PE ratio, making it more accessible for individual investors or those looking for undervalued stocks. Additionally, General Mills’ dividend yield of 7.36% is significantly higher than Humana's 1.01%, making it particularly attractive for income investors seeking regular dividend income.

Profit margins also highlight a stark difference: General Mills boasts a profit margin of 12.05%, substantially higher than Humana’s 0.82%. This indicates that General Mills is more efficient at turning revenue into profit, which could influence valuation and price stability, especially in economic downturns. Despite Humana’s larger size and higher market cap, its lower profit margin and higher valuation suggest it might be more susceptible to sector-specific risks within healthcare.

In terms of price stability, Humana’s 52-week high of $351.88 approaches its current price, indicating relative price consistency, whereas General Mills’ stock fluctuates between $31.85 and $55.19 over the year, offering more volatility but also potential upside given its lower price. Overall, the price comparison shows that while Humana is a premium healthcare stock, General Mills provides a more affordable, dividend-rich option for value and income-focused investors.